2026-2034年全球鐵蛋白檢測市場規模、佔有率、趨勢及成長分析報告

預計鐵蛋白檢測市場將從 2025 年的 10 億美元成長到 2034 年的 20.5 億美元，2026 年至 2034 年的複合年成長率為 8.34%。

由於缺鐵及其相關疾病的盛行率不斷上升，全球鐵蛋白檢測市場正經歷穩定成長。鐵蛋白檢測廣泛用於測量人體鐵蘊藏量，並幫助醫療專業人員診斷貧血、肝病和慢性發炎等疾病。人們對營養缺乏的認知不斷提高，以及對定期健康檢查重要性的日益重視，推動了全球醫院、診斷檢查室和診所對鐵蛋白檢測的需求。

推動該市場發展的主要因素之一是缺鐵性貧血發生率的上升，尤其是在婦女和兒童。意識提升宣傳活動的加強以及政府推廣早期診斷的舉措，促使更多人定期進行血液檢查。此外，檢查室中自動化診斷技術的日益普及提高了檢測的準確性和效率，進一步促進了鐵蛋白檢測市場的發展。

隨著醫療保健系統日益重視預防醫學和疾病早期檢測，鐵蛋白檢測市場預計將會成長。診斷設備的進步和先進檢測技術的整合將提升檢測能力。隨著人們對營養健康和慢性病管理的認知不斷提高，預計在整個預測期內，對鐵蛋白檢測的需求將穩步成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球鐵蛋白檢測市場：依產品分類

• 市場分析、洞察與預測
• 測量設備
• 試劑
• 成套工具

第5章：全球鐵蛋白檢測市場：依應用領域分類

• 市場分析、洞察與預測
• 貧血
• 血鐵沉著症
• 鉛中毒
• 懷孕
• 其他

第6章：全球鐵蛋白檢測市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 診斷檢查室

第7章 全球鐵蛋白檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Eurolyser Diagnostica GmbH
  • Cortez Diagnostics Inc
  • Pointe Scientific Inc
  • BioMrieux
  • Humankind Ventures Ltd
  • Aviva Systems Biology Corporation
  • Abnova Corporation
  • Cosmic Scientific Technologies
  • CTK Biotech Inc
  • Thermo Fisher Scientific Inc

The Ferritin Testing Market size is expected to reach USD 2.05 Billion in 2034 from USD 1.00 Billion (2025) growing at a CAGR of 8.34% during 2026-2034.

The global ferritin testing market is witnessing consistent growth due to the increasing prevalence of iron deficiency and related disorders. Ferritin tests are widely used to measure iron storage levels in the body, helping healthcare professionals diagnose conditions such as anemia, liver disease, and chronic inflammation. Growing awareness about nutritional deficiencies and routine health screening is driving the demand for ferritin testing in hospitals, diagnostic laboratories, and clinics worldwide.

One of the major drivers of this market is the rising incidence of iron deficiency anemia, particularly among women and children. Increasing healthcare awareness campaigns and government initiatives promoting early diagnosis are encouraging more individuals to undergo routine blood tests. Additionally, the growing adoption of automated diagnostic technologies in laboratories is improving testing accuracy and efficiency, further supporting the expansion of the ferritin testing market.

Looking forward, the ferritin testing market is expected to grow as healthcare systems emphasize preventive healthcare and early disease detection. Advancements in diagnostic equipment and the integration of advanced laboratory technologies will improve testing capabilities. As awareness of nutritional health and chronic disease management continues to rise, the demand for ferritin testing is projected to increase steadily over the forecast period.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instrument
• Reagent
• Kits

By Application

• Anemia
• Hemochromatosis
• Lead Poisoning
• Pregnancy
• Others

By End-use

• Hospitals
• Diagnostic Laboratories

COMPANIES PROFILED

• Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc, Pointe Scientific Inc, bioMrieux, Humankind Ventures Ltd, Aviva Systems Biology Corporation, Abnova Corporation, Cosmic Scientific Technologies, CTK Biotech Inc, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FERRITIN TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instrument Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FERRITIN TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Anemia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hemochromatosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Lead Poisoning Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pregnancy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FERRITIN TESTING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FERRITIN TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FERRITIN TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Eurolyser Diagnostica GmbH
  • 9.2.2 Cortez Diagnostics Inc
  • 9.2.3 Pointe Scientific Inc
  • 9.2.4 BioMrieux
  • 9.2.5 Humankind Ventures Ltd
  • 9.2.6 Aviva Systems Biology Corporation
  • 9.2.7 Abnova Corporation
  • 9.2.8 Cosmic Scientific Technologies
  • 9.2.9 CTK Biotech Inc
  • 9.2.10 Thermo Fisher Scientific Inc